The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Completion and toxicity rates of adjuvant chemotherapy in rectal cancer patients previously treated with neoadjuvant therapy and resection.
Christopher R. Oxner
Disclosure not yet available
Sun-Cheun Choi
Disclosure not yet available
Marjorie Jen Hein
Disclosure not yet available
Dean Lim
Disclosure not yet available
Stephen Shibata
Disclosure not yet available
Alessio Pigazzi
Disclosure not yet available